Protocols
1 protocol(s) meet the specified criteria
Drug: POMALIDOMIDE
Protocol No.TitleStatus
NCI9524A Phase I Study of Pomalidomide Given at the Time of Lymphocyte Recovery Following Induction Timed Sequential Chemotherapy with Cytarabine, Daunorubicin and Etoposide (AcDVP16) in Patients with Newly Diagnosed Acute Myeloid Leukemia (AML) and High-Risk MDSOpen